Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 15, No. 12, 2016, pp. 2719-2723
Bioline Code: pr16358
Full paper language: English
Document type: Research Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 15, No. 12, 2016, pp. 2719-2723
© Copyright 2016 - Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.
Clinical efficacy of radiotherapy combined with sodium glycididazole in the treatment of recurrent oesophageal carcinoma|
Jiao, Yu-Yan; Shen, Yu-Zhen; Liu, Yan; Yan, Hua; Wang, Jing & Li, Jian-Zhe
Purpose: To assess the clinical efficacy and side effects of radiotherapy combined with sodium
glycididazole in the treatment of recurrent esophageal carcinoma.
Methods: Ninety patients with locally recurrent oesophageal carcinoma who were admitted to the
Oncology Department at Taian City Central Hospital, Shandong, China, were randomly divided into a
treatment group (treated with radiotherapy and sodium glycididazole) and a control group (treated with
radiotherapy alone) in a randomized study. Short-term curative effects, median progression-free survival
(PFS), and side effects were compared between the two groups.
Results: The cure rate in the treatment group was 86.70 %, whereas that in the control group was
51.10 % (p < 0.05). Median PFS in the treatment group was 9.9 months versus 5.3 months in the
control group (p < 0.05). Side effects in both groups included alopecia, headache, nausea, vomiting and
leucopaenia, at level one or two. In this regard, the difference between the two groups was statistically
insignificant (p > 0.05).
Conclusion: Radiotherapy combined with sodium glycididazole shows a higher short-term curative
effect in the treatment of recurrent oesophageal carcinoma than radiotherapy alone.
Alopecia; Leucopaenia; Oesophageal carcinoma; Radiotherapy; Sodium glycididazole
Alternative site location: http://www.tjpr.org